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Who we are
Rethink	Mental	Illness	is	a	charity	that	believes	a	better	
life	is	possible	for	millions	of	people	affected	by	mental	
illness.	For	40	years	we	have	brought	people	together	to	
support	each	other.	We	run	services	and	support	groups	
across	England	that	change	people’s	lives	and	we	
challenge	attitudes	about	mental	illness.	
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Foreword
In	2012,	the	Schizophrenia	Commission	report	‘The Abandoned Illness’	
highlighted	major	problems	with	the	state	of	care	for	people	with	psychosis	
across	the	country.
It	revealed	the	true	extent	of	how	many	people	are	missing	out	on	crucial		
and	effective	treatments,	that	mental	health	wards	are	dangerously	over-
stretched	and	that	people	with	serious	mental	illnesses	are	dying	on	average	
15-20	years	younger	than	the	general	population,	mainly	from	preventable	
physical	health	conditions.	
Improvements	in	our	understanding	and	treatment	of	psychosis	mean	that	
this	should	no	longer	have	to	be	the	case.	We	know	which	techniques	and	
services	are	effective	in	helping	people	recover	from	psychosis,	and	which	offer	
commissioners	the	best	in	terms	of	value	for	money	and	health	outcomes.	In	
straitened	times,	it	is	more	important	than	ever	to	recognise	that	human	and	
economic	value,	prioritise	those	services	and	ensure	that	they	are	consistently	
available	for	everyone	that	could	benefit	from	them.	
That’s	why	we	are	delighted	to	present	this	important	new	research	by	the	
London	School	of	Economics	and	Political	Science,	which	offers	up-to-date	
evidence	about	the	most	effective	services	for	treating	psychosis,	both	in	terms	
of	helping	people	recover,	and	giving	commissioners	the	best	value	for	money.	
But	now	we	need	local	and	national	decision-makers	to	act	on	this	evidence	by	
putting	these	essential	services	in	place	in	their	local	communities.	Failing	to	do	
so	makes	no	sense	–	the	human	and	economic	costs	are	too	great.
We	are	calling	on	commissioners	to	take	urgent	action	now,	so	that	we	start	to	
make	high	quality	treatment	for	psychosis	a	reality	for	everyone	who	needs	it.	
Mark Winstanley
Acting	Chief	Executive	of	Rethink	Mental	Illness
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Executive summary 
The	health	service	spent	£2.0	billion	on	services	for	people	with	psychosis	in	
2012/13.	Over	half	(54%)	of	this	total	was	devoted	to	inpatient	care.	This	means	
that	spending	is	currently	skewed	towards	the	more	expensive	parts	of	the	
system,	at	£350	average	cost	per	day	for	inpatient	care	compared	with	£13	
average	cost	per	day	in	community	settings.
• Early Detection (ED) services
• Early Intervention (EI) teams
• Individual Placement and Support (IPS)
• Family therapy 
• Criminal justice liaison and diversion
• Physical health promotion, including health 
behaviours
• Supported housing
• Crisis Resolution and Home Treatment (CRHT) teams
• Crisis houses
• Peer support
• Self-management
• Cognitive Behavioural Therapy (CBT)
• Anti-stigma and discrimination campaigns
• Personal Budgets (PBs)
• Welfare advice 
Many of these interventions are shown to be cost-effective, in some cases due to the role they play in 
preventing or delaying relapse, or reducing the need for the most expensive care. Some have much wider 
benefits related to wider recovery outcomes, such as employment, settled housing and better physical 
health. There is particularly clear evidence for interventions such as EI teams, IPS for employment, CBT and 
CRHT teams. However, there is evidence to suggest that all of the above interventions contribute to recovery 
outcomes, reduced costs and/or better value for money. Illustrative examples of the savings incurred through 
particular interventions include:
• Early Intervention: net savings of £7,972 per person after four years. Over a ten-year period, £15 in costs 
can be avoided for every £1 invested.
• Smoking cessation: £1,255 to gain an extra Quality-Adjusted Life Year (QALY), which lies well below the 
upper threshold of £30,000 recommended by National Institute for Health and Care Excellence (NICE). 
• Peer support: £4.76 can be gained for every £1 invested. 
• CBT: Cost per QALY gained of £27,373 for CBT compared to usual care, which is below the upper threshold 
used by NICE.
Local and regional commissioning and pathway development should draw on this evidence, since these 
interventions are both clinically effective and many will contribute to savings to be reinvested in care. While the 
scope of this report is primarily at intervention level, the intention is to inform local implementation.
There is a strong business case for investing in the early intervention and community-based interventions 
proven to generate savings or value-for-money gains through reduced inpatient admission, or through other 
routes. 
This report provides the most up-to-date economic evidence to support the business case for investment in 
effective, recovery-focused services. Drawing on a wide range of data, evidence for the cost-effectiveness of 
recovery-focused interventions is set out:
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1. Introduction
In	December	2013,	following	discussions	with	the	Department	of	Health	and	
NHS	England,	Rethink	Mental	Illness	commissioned	a	study	that	would	build	on	
previous	work	–	including	the	Schizophrenia	Commission.	The	aim	of	this	new	
piece	of	work	was	to	prepare	new	economic	analyses	of	interventions	and	care	
pathways	for	people	with	schizophrenia	and	psychosis.	Findings	from	this	study	
are	described	in	this	report.
We briefly summarise our approach to the task in 
this section. Section 2 then sets out the national 
context for a business case for recovery-focused 
interventions. In section 3 we set out the economic 
evidence on a range of interventions and services. 
For each of these interventions we describe the 
context, the nature of the intervention, the evidence 
on effectiveness and cost-effectiveness, and the 
policy and practice implications. 
The study was undertaken by a team from the 
Personal Social Services Research Unit (PSSRU) 
at the London School of Economics and Political 
Science (LSE), the Centre for Mental Health, and the 
Centre for the Economics of Mental and Physical 
Health (CEMPH) at King’s College London. It was 
funded by a grant from the Department of Health via 
Rethink Mental Illness and from PSSRU reserves.
The intended outcome is to establish a clear business 
case to inform transformation in local leadership 
and the commissioning of services for people with 
schizophrenia and psychosis.
A wide range of interventions for people with 
schizophrenia and psychosis are analysed in the report. 
We focus particularly on those interventions which the 
available evidence suggests are not only effective, but 
also good value for money, including some that have 
the potential to generate cost savings in the NHS. 
The analysis is based on a review of the published 
research relating to each intervention, supplemented 
in some cases by new economic modelling 
undertaken specifically for this report.
The choice of interventions for analysis was agreed in 
discussion with Rethink Mental Illness: 
• To include a broad spectrum of interventions, 
ranging from the detection and treatment of 
severe mental illness in its early stages through 
to the promotion of long-term recovery, including 
not only the management of symptoms but also 
the achievement of personal goals which are 
held important by service users (e.g. improved 
educational and employment opportunities, stable 
housing and financial security.)
• Not to include interventions in the form of 
medication alone. The use of effective drug 
therapies is of course important in treatment 
regimes for schizophrenia and psychosis, but this is 
a large and complex area which is already very fully 
covered in the new NICE guideline on schizophrenia 
and psychosis published in February 2014.
• Not to include interventions relating in particular 
to the treatment of drug and alcohol problems. 
This decision was based on the relative lack of 
evidence on the cost-effectiveness of interventions 
in this area that relate specifically to people with 
schizophrenia and psychosis. 
Technical details of the methodology used in the 
analysis are described in a separate technical annex 
which will be made available on the Personal  
Social Services Research Unit website at the LSE 
(www.pssru.ac.uk). 
Key points to note here are that all costs and benefits 
are measured at 2012/13 prices, with past values 
adjusted using the health service pay and prices 
index produced by the Department of Health. Costs 
drawn from studies conducted outside the UK are 
converted using the Organisation for Economic 
Co-operation and Development (OECD) purchasing 
power parity indices. And economic impacts arising 
in future years are converted to present values using 
the public sector discount rate of 3.5% a year. 
The individual analyses in Section 3 – some 
quantitative, some narrative – provide more detail on 
the methods used in those particular intervention areas.
Our economic findings for those 15 interventions are 
summarised under each intervention heading. 
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2. The business case for recovery-focused interventions for 
schizophrenia and psychosis
According	to	the	NHS	programme	budget	published	by	the	Department	of	
Health	(2014a),	the	health	service	spent	£2.0	billion	on	services	for	people	
with	psychosis	in	2012/13.	Aggregation	of	data	relating	to	psychosis	given	in	
another	Department	of	Health	source,	the	National	Schedule	of	Reference	
Costs	(Department	of	Health,	2013),	produces	a	very	similar	estimate	of	
£1.9	billion.
The second of these sources provides the following breakdown of expenditure according to the various 
psychosis-related patient groupings or clusters used in payment by results for mental health.
Table 1. NHS expenditure on psychosis by cluster, 2012/13
Spending on first-episode psychosis (cluster 10) and on psychotic crises (cluster 14) each account for around 
10% of total psychosis-related expenditure, with most of the remainder going on the treatment of ongoing or 
recurrent psychosis of varying degrees of severity (clusters 11-13).
Further analysis of the reference costs data shows that spending on inpatient care for people with psychosis 
continues to account for more than half (54%) of all secondary mental health service spending on this group. 
The proportion of expenditure devoted to inpatient care ranges from 35% for cluster 11 (ongoing or recurrent 
psychosis, low symptoms) to 76% for cluster 14 (psychotic crisis). The national average cost of inpatient care 
is estimated at £350 a day in 2012/13. In comparison, the national average cost of a non-inpatient cluster day 
works out at £13.
Cluster days 
million
Expenditure 
£ million
Cluster 10 First-episode psychosis 6.7 187.2
Cluster 11
Ongoing or recurrent psychosis 
(low symptoms)
25.4 355.2
Cluster 12
Ongoing or recurrent psychosis 
(high disability)
16.1 369.6
Cluster 13
Ongoing or recurrent psychosis 
(high symptoms and disability)
9.6 374.9
Cluster 14 Psychotic crisis 2.0 205.4
Cluster 15 Severe psychotic depression 1.1 61.7
Cluster 16 Dual diagnosis 2.7 97.2
Cluster 17
Psychosis and affective disorder  
(difficult to engage)
4.3 218.6
Total 67.8 1869.8
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Planning for the future
Compared with some other spending programmes, 
health has fared relatively well in recent public 
expenditure settlements, but it remains the case  
that living within the constraints of a flat budget for 
health is a major challenge when set against the 
scale of demand and cost pressures facing the NHS. 
Such a requirement was embodied in the Quality, 
Innovation, Productivity and Prevention (QIPP) 
challenge announced in 2010 which required the  
NHS to make efficiency savings of £15-20 billion 
by 2015, and it is now clear that further savings of 
broadly this magnitude will be required over the 
next five years as well. There is no precedent in the 
history of the NHS for sustained improvements in 
productivity on this scale.
Severe financial restraint is almost certain to persist 
into the medium term, which calls for a strategic 
approach to commissioning and service planning. 
Among other things, this means avoiding cuts in 
effective service provision which increase costs later 
on. Such cuts may bring temporary relief but make 
little sense when budgets will be at least as tight 
tomorrow as they are today. 
There is some evidence that short-termist measures 
are occurring in commissioning. For example, a 
recent report by Rethink Mental Illness has found that 
50% of services providing Early Intervention  
for Psychosis (EIP) have experienced budget cuts 
in the past year, some by as much as 20% (Rethink 
Mental Illness, 2014). This is despite evidence that, 
even on a relatively short time horizon, these  
services are cost-saving from an NHS perspective 
in addition to generating wider benefits such as 
increased employment.
A number of other interventions analysed in this 
report show evidence of high returns, including 
financial savings in the NHS, and should therefore 
be incorporated in care pathways where this is not 
already the case. Many of these are relatively  
low cost, while in other cases the costs of 
implementation may be met by cutting back on 
related services which yield lower returns, e.g. 
introducing Individual Placement and Support in 
place of traditional vocational rehabilitation services 
such as sheltered workshops. 
The high unit cost of inpatient care – and the fact 
that such care accounts for over 50% of spending 
on psychosis – highlights the continuing importance 
of interventions which help to reduce bed use, 
particularly through the prevention of relapse.
An approach which may also in time offer the biggest 
scope for cost savings in mental health care is to 
promote and expand co-production, drawing on the 
resources of people who are currently using mental 
health services, for example in peer support roles, 
and on those of non-mental health agencies in the 
local community (education services, faith groups, 
hobby and leisure activities, friends, family etc.) which 
in many cases may already be helping people with 
severe mental health problems, but could do much 
more if actively supported by mental health services. 
The cultivation of these resources as a means of 
addressing capacity problems in the statutory sector 
is often not seen as the business of mental health 
services, still less as a priority. Co-production is a key 
element of the recovery approach, which provides a 
valuable overarching framework for the development 
of strategic commissioning and service planning at a 
time of spending restraint.
Commissioning cost-effective 
interventions for recovery
The term ‘recovery’ can be used in many ways. 
For clinicians it is associated with the treatment 
of symptoms and the concept of cure. But for 
many people with psychotic symptoms, cure is at 
best partial and often intermittent. Hence the term 
‘personal recovery’ (Slade, 2009) has emerged 
to refer to the process of learning how to live a 
meaningful and rewarding life, with or without 
enduring symptoms or vulnerabilities.
It is concerned with maintaining hope, finding 
meaning, and gaining purpose and a sense of control 
over those important life choices that are personally 
most valued by people with severe mental illness. 
These ideas have been drawn from a careful study  
of the experiences of service users and what they 
have found most helpful in supporting them to live 
their lives.
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The principles of recovery provide a new rationale 
for the organisation and delivery of mental health 
services which now underpins mental health service 
development in many countries, including the United 
States, Australia, New Zealand, Ireland and Scotland. 
In this country, the second objective of the 
Government’s mental health strategy No	Health	
without	Mental	Health	(Department of Health, 2011) 
is that “More people with mental health problems will 
recover”. This is defined as follows: “More people 
who develop mental health problems will have a good 
quality of life – greater ability to manage their own 
lives, stronger social relationships, a greater sense of 
purpose, the skills they need for living and working, 
improved chances in education, better employment 
rates and a suitable and stable place to live”. 
More recently, in the Government’s Closing	the	
Gap	document (Department of Health, 2014b), 
the first priority is that “High quality mental health 
services with an emphasis on recovery should be 
commissioned in all areas”.
The challenge for local commissioners, providers 
and practitioners is to develop ways of working 
which most effectively support and facilitate personal 
recovery. This will require changes to the way 
professionals practise, the types of services  
delivered and the culture running through 
organisations. These issues are being taken 
forward in a national programme part-funded by the 
Department of Health called Implementing Recovery 
through Organisational Change (ImROC) (Shepherd  
et al., 2010).
Evidence on the effectiveness and cost-effectiveness 
of a wide range of interventions for recovery in 
psychosis is provided in this report. In other cases 
the evidence base is limited, mainly because the 
application of recovery principles to service design and 
recovery is still relatively new. This applies, for example, 
to ‘recovery colleges’, an educational model which 
uses co-production by professional staff and service 
users to develop and deliver courses to students who 
may also be a mixture of service users and staff.
Changing the balance of the workforce to include 
more experts by experience may be considered in 
a wide range of recovery-oriented interventions. 
Recovery is about helping people with severe mental 
illness to live ordinary lives, including assistance 
with the central elements in all our lives – housing, 
employment, money and so on. In many of these 
areas there is now good evidence on which 
interventions are most effective in helping people 
with severe mental illness: for example, Housing 
First for housing, Individual Placement and Support 
for employment and specialist welfare advice for 
financial stability. 
In all these cases there is no reason why workers in 
these specialist services should not include people 
with relevant skills who also have lived experience 
of mental health problems. Given appropriate 
training and support to deliver services according 
to evidence-based models, they are likely to have 
significant advantages in terms of effectiveness and 
cost-effectiveness. 
Work is in hand in the ImROC context on developing 
a full specification of a service model for a recovery-
oriented service.
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3. The economic evidence
3.1 Early Detection services
A-La Park, Paul McCrone, Martin Knapp
Context
Many serious mental illnesses start before the age  
of 24. The largest gap between rates of serious 
mental illness in the general population and actual 
service utilisation is found in the 16-24 age group 
(Lennox, 2014). Early detection services may play an 
important role in bridging unmet needs for services 
between child and adolescent mental health teams 
and adult community mental health teams by 
enhancing continuity of care. It is also important 
because the longer the time between the onset of 
psychosis and the start of treatment (known as the 
Duration of Untreated Psychosis – DUP), the worse 
the prognosis can be (McGorry et al., 1996). Delayed 
treatment can lead to significant impairments in 
function and social outcomes. It can also have 
substantial economic costs not only for health but 
also for education, employment and criminal justice.
Intervention
It is not uncommon to see that terms such as Early 
Detection (ED) and Early Intervention (EI) are used 
interchangeably in the literature. What we mean 
by early detection services here are services that 
shorten DUP. They aim to target young people in 
the prodromal period: this means their symptoms 
are not yet clinically visible. These interventions can 
include a combination of low-dose antipsychotics/
antidepressants and Cognitive Behavioural Therapy 
(CBT), family intervention, assertive community 
treatment, GP education, increased contacts with 
psychiatrists, and vocational and educational support 
to encourage early recovery. Usual care refers to GP 
and counsellor care alone.
Evidence on effectiveness
There is evidence that it is possible to identify 
people who are at risk of developing psychosis 
(NCCMH, 2014). A recent systematic review and 
meta-analysis of 11 studies indicates a number of 
early detection interventions that can be effective 
(Stafford et al., 2013). CBT is effective in reducing 
transition to psychosis at 12 months. Omega-3 
fatty acids and integrated psychotherapy are also 
related to decreases in transition to psychosis at 12 
months (Stafford et al., 2013). According to work for 
the most recent NICE guideline on psychosis and 
schizophrenia, two studies for multi-focus public 
awareness campaigns in Norway and Singapore 
show significant reductions in DUP (National 
Collaborating Centre for Mental Health, 2014). 
However, GP education campaigns are not very 
effective (Lloyd-Evans et al., 2011).
Evidence on cost-effectiveness
In spite of an increasing number of studies on  
clinical effectiveness, very few economic evaluations 
have been performed. In the UK, there has been 
modelling of the cost effectiveness of early detection 
services in people having an at-risk state of 
psychosis based on the Outreach and Support in 
South London (OASIS) programme (Valmaggia et al, 
2009). During the first year, although the costs for 
the ED were £2,088 higher than usual care from a 
health and social care perspective, the difference in 
costs narrowed to £1,072 at two years by considering 
the costs associated with productivity losses (i.e. 
unemployment). 
McCrone and colleagues (2011) performed multiple 
economic evaluations for ED services by broadening 
the scope of the analysis to look at costs beyond 
the health care system (including costs to criminal 
justice systems, and the economic costs of suicide 
and unemployment). From this broad perspective the 
costs avoided by use of ED services would be greater 
than the costs of delivering ED services. 
Over two to five years cost-savings of £3,299 
per person per annum and £51.95 million at the 
national level in the UK were reported. And over 
the next five years, further annual savings of £45 
million could be achieved across the country.
In Australia, economic evaluations for early detection 
services comparing three interventions (CBT alone, 
medication alone, and the two in combination) found 
lower yearly costs to the health care system and to 
the economy as a whole compared to usual care. 
One reason is because they help reduce negative 
impacts on employment.
In addition, in this analysis relative to usual care, the 
cost of preventing one additional case of psychosis 
was £4,011 with CBT alone, £8,036 with medication 
alone, and £6,539 with CBT and medication in 
combination.
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Policy and practice implications
Bridging the gaps in services for young people at 
the key transitional period between childhood and 
adulthood can lead to cost savings in the long term, 
especially taking into account greater participation in 
employment and education. More empirical studies 
with longer-term follow-up periods are needed to 
confirm the effectiveness and cost-effectiveness for 
different interventions following detection of risk.
Conclusion
The longer the duration of untreated psychosis, 
the worse the prognosis can be. Investing in Early 
Detection and support services to reduce the risks 
of developing psychosis can have positive long term 
economic benefits.
Further details: A-La Park (A.Park@lse.ac.uk)
3.2 Early Intervention services
A-La Park, Paul McCrone, Martin Knapp
Context
Most first episodes of psychosis occur in 
adolescence or young adulthood. It is important 
to detect and treat these early as delayed action 
can lead to poor clinical and social outcomes, with 
potential consequences over the lifetime. Although 
there are a number of studies of Early Intervention 
(EI) that have looked at clinical effectiveness, there 
have been relatively few studies looking at economic 
impacts, particularly looking beyond the health and 
social care sectors.
Intervention
Our definition of EI was based on that of the  
Lambeth Early Onset (LEO) team in London. This 
consists of a team of mental health professionals 
including a consultant psychiatrist, trainee 
psychiatrists, clinical psychologists, community 
psychiatric nurses, occupational therapists and  
health care assistants. Individuals have access to 
services 365 days a year, with care including low-
dose atypical antipsychotics, Cognitive Behavioural 
Therapy, family counselling and vocational therapies 
(Craig et al., 2004). 
Standard care was assumed to be a community 
mental health service which did not include any 
component particularly targeted at people with early 
psychosis (Craig et al., 2004; McCrone et al., 2010).
Evidence on effectiveness
There is a growing body of literature on the 
effectiveness of EI services demonstrating positive 
outcomes in terms of clinical symptoms and 
vocational and social functioning (NCCMH, 2014). 
This builds on observed improvements in outcomes 
that have been reported in some EI services in 
England. For instance, one study looking at the 
impact on recovery rates within two years following 
the introduction of an EI service in Norfolk reported 
recovery rates of 52% compared with just 15% who 
had received support from traditional community 
mental health teams (Fowler et al., 2009).
Evidence on cost-effectiveness
Economic evaluations identified by a comprehensive 
systematic literature review (NCCMH, 2014) on 
economic aspects of EI include two studies in the 
UK (McCrone et al., 2009; McCrone et al., 2010), 
two Italian studies (Cocchi et al., 2011; Serretti et 
al., 2009), two Danish OPUS studies (Bertelsen, 
2008; Hastrup et al., 2013) and one in Australia 
(Mihalopoulos et al., 2009). 
Most studies demonstrate that EI services save costs 
and may also be more effective than standard care. 
A recent economic evaluation based on the OPUS 
study in Denmark shows that EI has a 97% chance 
of being cost-effective over five years (Hastrup et al., 
2013). A study with an eight-year follow-up in Australia 
showed that EI was less costly and more effective 
than standard care from a health service provider’s 
viewpoint (Mihalopoulos et al., 2009).
Our models (shown in Table 1) indicate that from a 
health and social care perspective, cost-savings of 
£5,738 in year one can be produced. From a broader 
societal viewpoint, early intervention generates cost 
savings of £2,234 per person over three years from 
improved employment and education outcomes. 
There are also annual savings of £895 per person for 
early intervention compared to standard care as a 
result of a longer-term reduced risk of suicide.
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Policy and practice implications
Our analysis supports the economic case for 
investing in EI services, particularly when impacts 
beyond health service use such as employment, 
education, homicide and suicide are considered. 
There are potentially both short and long-term 
savings to be gained relative to standard care.
Early intervention to manage symptoms of psychosis 
might also lead to more significant cost-savings for 
the economy as a whole through better coordinated 
approaches involving relevant public sector bodies 
beyond the health sector. Other areas for careful 
evaluation could be exploring the impacts on housing, 
homelessness and concordance to intervention.
The potential benefits to be realised through 
early intervention mean that local Clinical 
Commissioning Groups (CCGs) should work to 
provide sufficient resources to enable enough local 
EI teams to be established to fully meet anticipated 
levels of first episodes of psychosis, as well as 
meet the needs of individuals having brief psychotic 
experiences, symptoms of depression, anxiety
and loss of personal function, that can precede the 
onset of psychosis.
Conclusion
Early Intervention services for people experiencing a 
first episode of psychosis can help improve clinical 
outcomes. Not only does this help avoid substantial 
costs to the health and social care system but there 
are also further benefits through greater rates of 
participation in employment, as well as lower rates of 
suicide and homicide. Over a ten-year period, at least 
£15 in costs can be avoided for every £1 invested in 
early intervention.
 
Further details: A-La Park (A.Park@lse.ac.uk)
3.3 Employment support
David McDaid
Context
Rates of employment in the UK for people with 
schizophrenia remain very low, with only 5% to 15% 
in paid employment (Schizophrenia Commission, 
2012). This is not because people living with 
schizophrenia are incapable of working, but rather 
that they face challenges in finding opportunities to 
enter into paid employment, particularly but not only 
when economic conditions are tough. Workplaces 
may also not make sufficient adaptations to help 
individuals make the transition back into work. 
Negative attitudes, both among employers and 
employees, can also be a barrier to participation.
While paid employment will not be suitable 
for everyone, for most people participation in 
employment can be one key element of recovery. Not 
only does work reduce the risk of poverty, but it also 
helps promote social inclusion and self-esteem. It 
can have a positive impact on mental health status, 
which in turn may also help protect physical health. 
Table 2: Net savings per person for Early Intervention services 
Source: updated	figures	from	Park	et	al.	(2014)	using	2012-2013	prices
Year 1 (£) Years 1-3 (£) Years 4-10 (£)
Health care services 5,738
Employment 2,234
Homicide 514
Suicide 6,266
Total 5,738 2,234 6,780
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Exclusion from work incurs cost to the welfare 
system. Exclusion from work may also lead to  
higher use of health and social care services 
compared to people living with schizophrenia who 
remain in employment.
Intervention
There are a number of different actions that can 
form part of a strategy to help more people with 
schizophrenia obtain paid employment, but they can 
broadly be divided into two types of support: train	
and	place and place and train. The former focuses 
on the provision of training and often opportunities 
for sheltered employment with a view to building up 
the skills to obtain future competitive employment. 
Here we focus on place and train, using an approach 
known as Individual Placement and Support (IPS) 
where the aim is to help service users obtain 
competitive employment as quickly as possible and 
then offering them support and on the job training to 
help them to maintain employment. 
The IPS approach is based on a number of principles: 
competitive employment is the key objective; anyone 
with a mental health problem can participate; job 
searches are based on individual preferences; the 
job search is rapid, beginning within a month of 
contact; employment specialists are integrated into 
clinical teams; individualised time-unlimited support, 
continuing after employment is obtained, for both 
employees and employer; and welfare benefits 
counselling through the transition from benefits to work. 
Implementation may be helped by the addition of 
IPS trainers whose role is to improve awareness and 
understanding among clinicians about the benefits of 
IPS and to help local employment specialists engage 
with clinical colleagues and employers.
Evidence on effectiveness
There is a growing body of evidence that IPS leads to 
greater rates of long-term competitive employment 
than other approaches. Randomised Controlled 
Trials (RCT) report that IPS leads to higher rates of 
competitive employment, duration of employment 
and hours worked compared to different forms of 
place and train supports (Kinoshita et al., 2013). 
However, outcomes appear to be more positive in 
US-based evaluations that those outside the US, 
(Bond et al., 2012). Programmes are effective not 
only for young people (Rinaldi et al., 2010) but also 
for middle-aged and older people with schizophrenia 
(Twamley et al., 2012). One multi-country European 
trial found that use of IPS was also associated 
with improved clinical outcomes, including rates 
of rehospitalisation, compared to place and train 
programmes (Burns et al., 2009; Kilian et al., 2012). They 
can be embedded successfully into Early Intervention 
in Psychosis (EIP) teams (Abdel-Bakri et al., 2013).
Evidence on cost-effectiveness
There is consistent evidence that IPS can be cost-
effective compared to traditional place and train models. 
The six-country EQOLISE study, including England, 
which looked at the costs and health and social care 
outcomes of IPS and traditional vocational services, 
reported both lower costs and better employment 
outcomes for IPS services (Knapp et al., 2013).
Including IPS services within an EIP team is also 
cost-effective, with the improved employment-related 
outcomes strengthening the case for investing in 
these teams (Park et al., 2014). Given that a key 
challenge is the effective implementation of IPS, we 
have looked at the economic case for incorporating 
IPS trainer support into an IPS programme. 
Assuming an annual cost of £50,000 per annum 
for the provision of the IPS trainer, with modest 
levels of additional success in achieving competitive 
employment this also promises to be cost-effective.
Policy and practice implications
IPS is a cost-effective intervention, with better 
outcomes and with costs that are the same or 
even lower than traditional vocational support 
services. However, access to IPS services is variable 
in England, and the approach may not be fully 
implemented, meaning that lower levels of improved 
employment are achieved (Boardman and Rinaldi, 
2013). This appears to have been the case in one 
two-year evaluation which did report improved 
employment rates compared to usual support, but at 
much lower levels than seen in international studies 
(Heslin et al., 2011; Latimer 2010). 
Employing IPS trainers could potentially help improve 
implementation and improve awareness in both 
mental health professionals and service users of the 
benefits of employment in general and the approach 
offered by IPS. This would help in justifying increased 
investment in these employment supports. Only 
modest levels of improvement are required to justify 
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such an investment, but more evaluations of the use 
of IPS trainers on the success of local IPS services 
are needed to confirm this.
Conclusion
IPS programmes are cost-effective, but they may 
not be well implemented. Potentially, employing IPS 
trainers to work with mental health professionals 
and service users could help implementation. While 
evidence on their impact is limited only modest 
levels of improvement in employment rates would be 
required to justify such an investment. 
Further details: David McDaid (D.McDaid@lse.ac.uk)
3.4 Family therapy
Alison Andrew
Context
Family and friends of a person with schizophrenia are 
often hugely affected by the condition and may be 
vitally involved in any road to recovery. However, they 
can often feel isolated by mental health services and 
lacking in the knowledge they need to help a relative 
with schizophrenia (Schizophrenia Commission, 
2012). The aims of family therapy are jointly to 
improve the wellbeing of those close to the person 
with psychosis, and to support them to play a part in 
the person’s recovery.
Intervention
‘Family therapy’ refers to a range of psychosocial 
interventions for people who have a significant 
emotional connection to someone with schizophrenia. 
Interventions involve providing information about 
schizophrenia, discussing ways of supporting a 
relative or friend with the condition, and resolving 
practical problems. A central aim of family therapy is 
to reduce the level of ‘expressed emotion’ within the 
family. In practice, this refers to decreasing levels of 
criticism, hostility and emotional over-involvement 
that individuals with schizophrenia may be subjected 
to within family contexts.
Evidence on effectiveness
A systematic review of Randomised Controlled Trial 
(RCT) evidence suggests that family therapy could 
reduce the probability of hospitalisation by around 
20%, and the probability of relapse by around 45% 
(Pharoah et al., 2010). The primary mechanism 
by which these effects occur seems to be better 
adherence with medication: poor adherence is 
estimated to fall by 40% as a result of family 
therapy. The review also suggests there is evidence 
for improved social functioning (being able to live 
independently), which in turn relieves pressure on 
family. However, the sample sizes are small and the 
quality of evidence is low for both these outcomes.
Evidence on cost-effectiveness
An economic model was built to weigh up the costs 
associated with providing family therapy against the 
savings associated with this intervention. Evidence 
on the impact of family therapy on hospital admission 
rates is drawn from the most recent systematic review 
of the impacts of family therapy (Pharoah et al., 2010) 
and used to update baseline probabilities of being 
admitted to hospital. Different assumptions are made 
on both the length of admissions and the cost per 
day of admissions to help determine how likely family 
therapy is to be cost-effective. 
Even with a relatively large margin of error, the 
estimated mean economic savings to the NHS 
from family therapy are quite large: £4,202 (95% 
confidence interval (CI): £569, £6,943) per individual 
with schizophrenia over a three-year period. There is 
a 97% chance that family therapy will be cost-saving: 
that is, the costs of providing family therapy will be 
more than outweighed by savings made in the health 
care system.
It is likely that the model underestimates savings from 
family therapy since it only considers those arising 
from a reduction in hospitalisation rates. Other areas 
for savings may include: decreased service use from 
family members, increased employment rates among 
family members, an increase in the ability to live 
independently, and shorter hospital stays. In addition, 
this economic analysis does not place any monetary 
value on improvements in mental health or wellbeing 
for either the individual with schizophrenia or family 
members. If such benefits were quantified, the cost-
effectiveness argument for providing family therapy 
would be even stronger.
Policy and practice implications
Although family therapy (or ‘family intervention’) 
is recommended in both the 2009 and 2014 NICE 
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guidelines, it is often not available to many service 
users. The economic evidence presented here 
supports the case that such interventions could lead 
to cost saving for the NHS. They are cost-effective 
even before the benefits of the intervention for 
recovery are taken into account. This, on top of a 
strong case for supporting those people who love 
and care for someone with schizophrenia, provides 
support for the idea that access to family therapy 
should be expanded. 
Conclusion
Family and friends of people with schizophrenia are 
deeply affected by the condition and can also be 
key to aiding recovery. Current evidence suggests 
that offering family therapy, specifically designed to 
help family and friends support the individual with 
schizophrenia, is likely to result in cost savings for the 
NHS as well as improved outcomes for both those 
receiving the intervention and the service user.
Further details: Alison Andrew 
(Alison.Andrew1@gmail.com)
3.5 Criminal justice liaison and 
diversion
Michael Parsonage
Context
Many people in the criminal justice system have 
complex mental health needs which are often poorly 
recognised and inadequately managed. Large 
numbers end up in prison, a high-cost intervention 
which is inappropriate as a setting for mental health 
care and ineffective in reducing subsequent re-
offending. The overall size of the prison population 
has more than doubled in the last 20 years, and 
prevalence studies suggest that up to 90% of all 
prisoners have some kind of mental health problem, 
including up to 10% with probable psychosis (Harding 
et al., 2007; Singleton et al., 1997; Stewart, 2008).
Intervention
Mental health liaison and diversion services aim 
to identify people with mental health problems 
coming into contact with the police and courts and 
direct them towards appropriate mental health care, 
rather than prison. For the relatively small number 
of offenders with psychosis who have committed 
serious offences, the most appropriate alternative 
to prison is placement in an NHS secure hospital. 
However, about three-quarters of all people sent 
to prison each year receive sentences of less than 
12 months. For those in this group affected by 
psychosis, the most appropriate form of diversion is 
to a suspended sentence or community order instead 
of prison, combined with a package of community-
based mental health support.
The concept of liaison and diversion for mentally 
disordered offenders is not a new one, having first 
been endorsed by the Home Office in 1990, but the 
provision of services remains patchy in coverage and 
highly variable in scale and quality. Only about a third 
of all police custody suites and courts are served by 
any kind of liaison and diversion service.
Evidence on effectiveness and cost-
effectiveness
The underlying evidence base on the effectiveness 
and cost-effectiveness of this intervention is 
relatively slight. Most work on liaison and diversion 
is descriptive rather than evaluative. Only a handful 
of studies use high-quality research methods 
including the use of control groups, a longitudinal 
element, proper costings and quantified measures 
of outcomes (Kane et al., 2013; Scott et al., 2013). 
Little is known about the longer-term impact on key 
outcomes such as mental health and re-offending. 
Despite these limitations, the overall balance of 
evidence and expert opinion is that mental health 
liaison and diversion has a number of positive 
impacts. These include cost and efficiency savings 
in the criminal justice system, improved identification 
of offenders with mental health problems, and better 
access to appropriate mental health care. The case 
for liaison and diversion is further strengthened when 
set against the alternative of imprisonment. Prison 
is not only costly at around £10,000 per person for 
a 12-week stay, but is also a very poor therapeutic 
environment, likely to exacerbate rather than improve 
a mental health problem.
Because of limitations in the quantity and quality of 
the available evidence, it is not possible at this stage 
to quantify or model the costs and benefits of liaison 
and diversion for offenders with psychosis.
14 Rethink Mental Illness. Investing in recovery.
Policy and practice implications
The Government has allocated around £25 million 
for the development of existing liaison and diversion 
services, including 10 pilot sites which will be testing 
a ‘core model’ of provision. This will include an all-
ages service covering young offenders (those aged 
10-18) as well as adults. Evaluation of the pilot sites 
will be undertaken to support a business case for the 
roll-out of a national network of liaison and diversion 
teams serving every police custody suite and court in 
the country by 2017.
From an NHS perspective, the planned expansion 
of liaison and diversion services is likely to result in 
some increase in costs in the short term. The longer-
term impact on costs is, however, much less clear-
cut. In particular, it is important to note that the peak 
age for offending is very much the same as the peak 
age for first onset of psychosis (around ages 15-25), 
and liaison and diversion services may well be able to 
play a role in the quicker identification of psychosis in 
a group otherwise hard to engage. 
Conclusion
The bulk of cost savings are likely to arise in the 
criminal justice system. In the light of this, there is 
a good case for saying that these services should 
be commissioned on the basis of joint funding from 
mental health and criminal justice agencies.
Further details: Michael Parsonage 
(Michael.Parsonage@centreformentalhealth.org.uk)
3.6 Physical health interventions
A-La Park, Paul McCrone, Martin Knapp
Context
People with schizophrenia are at high risk of 
physical morbidity and premature mortality, 
including from cardiovascular disease and type 2 
diabetes, compared with the general population. Life 
expectancy is reduced by up to 20 years compared 
with the general population (Rethink Mental Illness, 
2013). More than half of those with early psychosis 
are smokers (Myles et al., 2012). In addition, young 
people experiencing a first episode of psychosis may 
be vulnerable to rapid weight gain, due to the effects 
of medication.
It is also important to consider older people with 
chronic schizophrenia and enduring comorbid 
physical conditions. They are likely to be exposed 
to elevated risks of having metabolic disorders that 
increase the risk of cardiovascular disease and 
diabetes, partly due to poor lifestyles and long-term 
use of multiple medications. Obesity can contribute 
to self/social stigma and may lead to lower rates of 
contact with health services and voluntary withdrawal 
from drug regimens, which could in turn result in 
increased relapse rates and other health problems.
Intervention
Several different interventions are examined here:
• Smoking cessation model – a ten-week 
combination of pharmacological treatment including 
bupropion, Cognitive Behavioural Therapy (CBT) 
and Nicotine Replacement Therapy (NRT) was 
compared to ten weeks of CBT and NRT alone.
• Weight-management model – the intervention 
is a combination of psycho-education, nutritional 
and/or exercise counselling, compared with usual 
care where a minimum level of advice on lifestyle is 
offered over three months.
• Body Mass Index (BMI) management model – 
the intervention was the delivery of 12 90-minute 
group-sessions of a manualised healthy lifestyle 
programme over a six-month period. Modules of 
the programme included advice and counselling 
on diabetes risk, healthy eating habits and levels of 
physical activity. Self-monitoring was an important 
element of the programme and participants 
received pedometers to encourage them to 
monitor the number of steps walked. Raffles 
provided rewards to participants to help encourage 
continued participation. Usual care refers to GP 
visits and referrals to dieticians.
Evidence on effectiveness
Smoking cessation: A review of eight RCTs of 
psychological interventions and/or medications 
to reduce smoking shows moderate effects but 
significant effect sizes (Banham and Gilbody, 
2010). The authors indicate that smoking cessation 
strategies for the general population can be equally 
effective for people with severe mental illness. 
Weight management: A number of systematic 
reviews have looked at the effectiveness of non-
pharmacological interventions. The common 
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finding is to recommend a combined intervention 
to promote the level of physical activity and better 
nutrition. There is good evidence on benefits from 
non-pharmacological interventions (Alvarez-Jimenez 
et al., 2008; Caemmerer et al., 2012). The most 
recently updated NICE guidance also suggests a good 
evidence base for behavioural interventions in the short 
term in terms of their impacts on abdominal obesity/
waist circumference, intermediate metabolic risk 
factors such as BMI, glucose levels, blood pressure, 
and quantity and quality of life (NCCMH, 2014). 
BMI management: According to a systematic 
review, lifestyle interventions can also be effective 
in reducing BMI for middle-aged adults (mean age 
53) adults with chronic schizophrenia and type 2 
diabetes, regardless of whether delivered in inpatient 
or outpatient care settings (Cimo et al., 2012).
Evidence on cost-effectiveness
Smoking cessation model: At base case, from 
the NHS perspective, the costs of intervention per 
quitter are £6,697 at 12-month follow-up in the 
intervention group and £23,453 in the control group. 
The difference in costs between the intervention and 
control group is £1073 for one additional year of life. 
It costs £1,255 to gain an extra Quality-Adjusted Life 
Year (QALY), which lies well below the threshold of 
£20,000 to £30,000 recommended by NICE. Even 
when model assumptions on the cost of intervention, 
cost of death and the risks of having physical health 
problems are varied the results are robust: the 
intervention remains cost-effective (Winterbourne et 
al., 2013).
Weight gain model: A dynamic model was 
constructed based on a hypothetical cohort of 1000 
young people with first-episode psychosis. At base 
case, the model resulted in a cost of intervention of 
£1,016 per QALY gained, which is again well below 
the NICE recommended willingness-to-pay for 
cost-effectiveness. When exploring uncertainty, all 
parameters are robust except the intervention effects. 
When using 12-month follow-up data, compared with 
usual care, the intervention was no longer cost-effective 
compared to usual care (Winterbourne et al., 2013).
BMI model: From the NHS perspective, in the 
base case analysis, a Group-based Lifestyle (GL) 
intervention for middle-aged adults with chronic 
schizophrenia and type 2 diabetes is more effective 
for modest costs in achieving an additional case 
of BMI loss and gaining an extra QALY compared 
with usual care. The incremental cost per QALY 
gained is less than £700. This calculation assumes 
that each group session will be attended by eight 
people and that they will complete a 12-session 
course of therapy. However, even with a lower rate of 
attendance the intervention will remain cost-effective 
in most circumstances.
Policy and practice implications
Overall, these interventions for people with first-
episode psychosis can be cost-effective strategies, at 
least in the short term. 
There are also opportunities to promote the physical 
health of specific population groups, including 
middle-aged adults living with psychoses. A group-
based lifestyle intervention is a promising option for 
middle-aged adults with chronic schizophrenia and 
comorbid type 2 diabetes, taking into account BMI 
loss achieved and QALYs gained. Refresher sessions 
may help prolong the beneficial effects accrued 
over time, but little is known about the long-term 
benefits or about the level of continued participation 
in these sessions. More empirical studies are also 
needed to confirm the impact of these physical health 
interventions on outcomes and costs over a longer 
time period.
Conclusion
These economic analyses show that interventions to 
help people living with schizophrenia to quit smoking 
and to prevent weight gain have a high probability of 
being cost-effective, relative to standard care. 
Further details: A-La Park (A.Park@lse.ac.uk)
3.7 Supported housing
A-La Park, David McDaid and Martin Knapp
Context
People with severe mental illness are at high risk of 
becoming homeless (Herman et al., 1998), and those 
with a history of homelessness tend to go through a 
vicious and costly circle of psychiatric hospitalisation 
and unstable housing status (Rog et al., 2014). 
Supported housing interventions seek to help those 
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with complex needs in achieving independent living 
in the community and prevent the damaging spiral of 
hospitalisation and homelessness.
Intervention
An integrated supported housing intervention is 
modelled. This refers to a service which helps people 
with severe mental illness develop life-skills through 
time-limited supported housing with different levels of 
intensity of support. Key workers co-ordinate support 
from other relevant public organisations, including the 
NHS and criminal justice system.
The supported housing option, described 
as Dispersed Housing, consists of scattered 
accommodation in the local community with support 
for 12 months. This is compared with Congregated 
Housing, which offers 24/7 staffed accommodation 
over the same period. In both cases, service 
users are expected to gradually move on to more 
independent living arrangements in the community.
Evidence on effectiveness
Internationally, there are studies reporting 
positive effects of successful supported housing 
programmes. In the USA, a study of chronically 
homeless adults with severe mental illness in 
California receiving an integrated programme 
providing housing and health care services reported 
fewer days spent homeless with better quality of life, 
compared to usual care (Gilmer et al., 2010).
Housing First, a Canadian programme providing 
scattered-site apartments plus assertive community 
treatment for people with high needs over 12 months, 
shows a wide variety of positive outcomes. These 
include better housing status, better quality of life 
in various domains (living situation, safety, leisure, 
finances, family/social relations), community ability 
(social skills, adaptation) and improved psychiatric 
symptoms (Patterson et al., 2013; Tsemberis, 2013). 
The findings are consistent with systematic reviews 
(Coldwell & Bender, 2007; de Vet et al., 2013). Most 
participants in Housing First at the four-year follow-up 
point were able to sustain permanent independent 
housing status (Stefancic and Tsemberis, 2007).
The Housing First model as seen in North America 
is not seen in England in full, although some 
elements of the Housing First approach are being 
implemented. For example, the Next Step project 
by the Manchester Methodist housing association 
provides independent accommodation with some 
support services made available, e.g. help and 
support on managing benefits and paying bills. This 
study reported 17 out of 19 service users achieved 
independent living after participating in the supported 
housing programme (Department of Health, 2011).
Evidence on cost-effectiveness
Recent international evidence on supported housing 
programmes suggests reductions in participants’ 
use of inpatient care and Accident and Emergency 
(Russolillo et al., 2014). One study found that 
increased numbers of outpatient visits were offset 
by reductions in the use of more costly inpatient 
and emergency services and in contacts with the 
criminal justice system (Gilmer et al., 2010). Economic 
modelling was used to explore the implications of 
supported housing in a UK setting, with intervention 
costs based on programmes implemented in 
Manchester for Congregated and Dispersed Housing. 
At base case, the results show that Dispersed 
Housing is both more effective and less costly than 
Congregated Housing. The dispersed independent 
living option is therefore a dominant strategy that 
should be considered for recommendation. 
Policy and practice implications
There is some international evidence that suggests 
that there is a good economic case for using this 
approach for people with severe mental illness. 
Further work is needed to confirm the case in this 
country taking into account local contextual factors 
such as the nature of the housing market and the 
housing benefit system. Nevertheless, initial findings 
are positive.
A co-ordinated approach across different sectors 
is critical for successful outcomes. A stepped care 
approach can include time-limited independent 
housing, as well as intense levels of floating support 
for perhaps six to eight weeks when individuals move 
to fully independent accommodation.
Conclusion
Clinical Commissioning Groups (CCGs) and local 
authorities should consider how they can ensure 
the availability of housing support services for their 
populations.
Further details: A-La Park (A.Park@lse.ac.uk)
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3.8 Crisis Resolution and Home 
Treatment teams
Valentina Iemmi
Context
Schizophrenia usually results in at least one inpatient 
stay and a high probability of readmission (Allardyce 
and Os, 2010). Fourteen per cent of the 220,000 
people living with schizophrenia in England receive 
inpatient care each year, including 5% who are 
compulsorily admitted under the Mental Health Act 
(Schizophrenia Commission, 2012). 
The average cost of an inpatient bed in England is 
£350 a day (Department of Health, 2013), while the 
median length of stay for schizophrenia is 38 days, 
giving a total cost per typical admission of £13,300. 
Compulsory admissions are longer and more 
expensive (Andrew et al., 2012). The high costs of 
inpatient care mean that crisis care interventions 
aimed at reducing the need for admission have the 
potential to produce important savings.
Intervention
Crisis Resolution and Home Treatment (CRHT) teams 
aim to reduce inpatient admissions and readmissions. 
Multi-disciplinary teams working 24 hours a day, seven 
days per week provide assessment and subsequent 
intensive treatments at home for people undergoing 
a severe mental health crisis with the aim of avoiding 
hospitalisation (NCCMH, 2014). They also work to 
reduce any hospital stay by facilitating earlier discharge 
by ensuring that ongoing support can be provided at 
home. The intervention lasts for a few weeks, until the 
crisis has resolved and the service user is discharged 
to other services for long-term support.
CRHT teams were introduced in the NHS following 
recommendations in the 1999 National Service 
Framework for mental health (Department of Health, 
1999). While their provision is no longer mandatory, 
teams are to be found across England.
Evidence on effectiveness
A Cochrane review of six RCTs found CRHT teams 
to be effective in reducing hospital admissions in 
people with severe mental health conditions, reducing 
family burden, improving some clinical outcomes, 
and increasing both patient and carer satisfaction 
(Murphy et al., 2012). A more recent review of 37 trials 
and other types of less rigorous reported a modest 
positive impact on hospital admissions and lengths of 
stay (Carpenter et al., 2013).
Evidence on cost-effectiveness
A review of the economic evidence on schizophrenia 
(Andrew et al., 2012) and the recent NICE guideline on 
schizophrenia (Department of Health, 2013) identified 
two economic studies on CRHT teams, both 
suggesting likely savings. In the first, a prospective 
controlled trial comparing service costs before and 
after the implementation of a CRHT team found a 
reduction in the mean total cost of services of 17% 
over six months, although this was not statistically 
significant (McCrone et al., 2009a). 
In the second, a Randomised Controlled Trial (RCT) 
of a CRHT team compared to standard care showed 
a statistically significant reduction in the mean total 
cost of services of 30% over six months (McCrone et 
al., 2009).
Policy and practice implications
The Mental Health Crisis Care Concordat 
(Department of Health, 2014) sets out four core 
principles of care for people in mental health crisis: 
support before the crisis, emergency access to crisis 
care, treatment when in crisis, and recovery and 
prevention of future crisis. The Concordat expects 
local commitment and partnership of health, criminal 
justice and local authority agencies.
A National Audit Office report (2007) estimated that 
£14.3 million (at today’s costs) could be saved each 
year if all CHRTs were in contact with just over 50% 
of all people at risk of admission, and that £61.6 
million a year in costs might be avoided if contact 
rates increased to 90%. Among innovative crisis 
services, mental health telephone triage in psychiatric 
crisis has been introduced in other countries (Sands 
et al., 2013) and is currently being piloted and 
evaluated in this country.
Conclusion
CRHT teams can help reduce the need for hospital 
admission, and can therefore generate savings. The 
costs of services for people with psychosis can be 
reduced by up to 30% through this service model.
Further details: Valentina Iemmi (v.iemmi@lse.ac.uk)
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3.9 Crisis houses
Valentina Iemmi and David McDaid
Context
Over the last decade, alternative residential care 
services in community settings have been developed, 
with the aim of helping people with schizophrenia 
onset of crisis, and therefore the need to be admitted 
to hospital. 
Intervention
Crisis houses offer a community-based residential 
alternative to acute psychiatric wards for people  
with schizophrenia. Crisis houses are staffed 24 
hours a day by trained mental health staff or support 
workers, helping with treatment planning and day-
to-day activities. While all are outside the hospital 
setting, the term ‘crisis house’ can cover very  
diverse models of practice using short-term 
residential stay: clinical crisis houses, specialist  
crisis houses, crisis team beds, recovery houses, 
and other non-clinical alternatives mainly managed 
by the third sector with few staff with professional 
qualifications (JCPMH, 2014).
Evidence on effectiveness
Two studies from the UK have reported improvements 
in symptoms and functioning. One of these focused 
on a crisis house for women, but only 20% of the 
service users had a diagnosis of schizophrenia 
(Howard et al., 2010). The other study looked at the 
experiences of 43 people who used a crisis house in 
Liverpool, but no information on the clinical diagnoses 
of these people was provided (Ryan et al., 2011). 
Another recent evaluation of a Rethink Mental 
Illness Crisis House reported improved recovery 
outcomes, including better management of mental 
health, identity and self-esteem, trust and hope, and 
self-care, although only 7% of service users in this 
study had a diagnosis of schizophrenia (Larsen and 
Griffiths, 2013). 
Adopting a broader definition of crisis houses to 
include different types of non-hospital crisis beds, 
one study in England compared five residential 
alternatives to standard acute inpatient care (clinical 
crisis houses, short-stay wards, crisis team beds 
and two non-clinical alternatives). About 40% of 
service users had symptoms or a formal diagnosis 
of psychosis. This study reported a significant 
improvement in severity and functioning at discharge 
(Slade et al., 2010). A significant increase in 
satisfaction with treatment was also found for these 
residential alternatives to psychiatric inpatient care 
(Osborn et al., 2010). 
Evidence on cost-effectiveness
In England, an RCT of women’s crisis houses 
compared with standard inpatient care showed a 
decrease in symptoms, an increase in functioning 
and quality of life, and a decrease in mean total 
cost of 17% over three months (Howard et al., 
2010). However, this difference in cost was not 
statistically significant. Only 20% of service users 
in this study had a diagnosis of psychosis. Looking 
at the economic analysis of the English study of five 
residential alternatives to standard acute inpatient 
care (clinical crisis houses, short-stay wards, crisis 
team beds and two non-clinical alternatives), on 
average costs were 22% lower than traditional 
services, although this difference in costs was not 
statistically significant (Byford et al., 2010). 
Policy and practice implications
The evidence base is very limited, with little evidence 
in a UK context focusing on the experiences, 
outcomes and costs of people with schizophrenia. 
The diversity in the types of service that can be 
labelled as crisis houses also makes assessment of 
effectiveness and cost-effectiveness difficult.
Conclusion
Potentially, crisis houses and other similar alternatives 
to inpatient care may be equally effective, but 
delivered at lower cost. Crisis houses are also viewed 
more favourably by service users. 
Further details: Valentina Iemmi (v.iemmi@lse.ac.uk)
3.10 Peer support 
Valentina Iemmi and Michael Parsonage
Context
Recovery from schizophrenia is not only about 
symptom remission. It also relates to improvement 
in a range of personal or social outcomes such as 
employment or educational involvement, independent 
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living, reduced dependency on welfare support, and 
better social networking (Liberman et al., 2002). 
Intervention
Peer support has been defined as ‘social emotional 
support, frequently coupled with instrumental 
support, that is mutually offered or provided by 
people having a mental health condition to others 
sharing a similar mental health condition to bring 
about a desired social or personal change’ (Solomon, 
2004). Peer support workers receive training and 
supervision and may be employed in a variety of 
ways in mental health services, either in addition to 
traditional staff or instead of them in certain specific 
roles. Peer support may have a therapeutic value 
not only for the mental health service users who are 
supported but also for the peer workers themselves.
Evidence on effectiveness
The evidence base remains limited and inconclusive. 
A Cochrane review, drawing on 11 Randomised 
Controlled Trials, found little evidence of any 
significant impact on outcomes (Pitt et al., 2013) 
and a similar conclusion is reported in the new 
NICE guideline on psychosis (NCCMH, 2014). Other 
reviews, drawing on a wider range of evidence, have 
come to more positive conclusions across a range of 
outcomes (Repper et al., 2013), but findings are not 
replicated across all studies and the overall quality of 
the evidence is poor.
Evidence on cost-effectiveness
Analysis by the Centre for Mental Health of six 
published studies with relevant data suggests that the 
economic case for the use of peer support workers 
in mental health teams is promising. They can help 
generate a reduction in costs because of reduced use 
of psychiatric inpatient care, with shorter admissions 
and fewer readmissions (Trachtenberg et al., 2013). 
In all six studies, peer support resulted in improved 
or unchanged health benefits. The value of bed-days 
saved per peer support worker ranged from £42,653 
to £146,330 over six months, and from -£44,578 to 
£245,515 over 12 months. Using a weighted average 
across all studies would suggest that £4.76 would be 
gained for every £1 invested. However, the authors 
noted that this evidence is limited both in quantity 
and quality. Furthermore, all the studies used for 
these calculations were from the US and Australia, 
which may restrict the applicability of their findings to 
the UK context. 
Other RCTs show either no difference in hospital 
rates over 12 months, possibly due to peer support 
workers adopting the attitudes of other colleagues 
(Schmidt et al., 2008), or inconclusive findings 
(Simpson et al., 2014). 
Policy and practice implications
The employment of peer support workers in 
statutory mental health services is a relatively 
recent development in this country, and their overall 
numbers are still limited (Repper et al., 2013). 
However, the peer support role was recognised in 
the Government’s 2011 mental health strategy for 
England (Department of Health, 2011) and highlighted 
as one possible intervention in the implementation 
framework that followed (Department of Health, 
2012). Similarly, the Schizophrenia Commission (2012) 
recommended that ‘all mental health providers should 
review opportunities to develop specific roles for peer 
workers’, emphasising the need to assure appropriate 
training and workplace support for peer support 
workers to guarantee their effectiveness and safety. 
Conclusion
There is some limited evidence that peer support 
for people with schizophrenia and psychosis may 
decrease hospitalisations and service use, and 
increase recovery, quality of life, and satisfaction 
in the short term. Initial modelling work suggests a 
potential £4.76 in costs averted for every £1 invested. 
This is promising enough to invest in more peer 
support workers and then carefully evaluate their 
costs and effectiveness.
Further details: Valentina Iemmi (v.iemmi@lse.ac.uk)
3.11 Self-management
Valentina Iemmi and Michael Parsonage
Context
Recovery in people with schizophrenia results 
in management of symptoms, participation in 
employment or education, independent living, reduced 
dependency on welfare support, and peer relationships 
(Liberman et al., 2002). Recovery is associated with 
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better health and social care outcomes (Helldin 
et al., 2007) and reduced costs (Hjortsberg et al., 
2011). Interventions supporting recovery are likely to 
produce better health and social outcomes and help 
avoid some health and social care costs.
Intervention
Self-management programmes aim to improve 
an ‘individual’s ability to manage symptoms, 
treatment, physical and psychosocial consequences 
and lifestyle changes inherent with living with a 
chronic condition. Efficacious self-management 
encompasses the ability to monitor one’s condition 
and to affect the cognitive, behavioural and emotional 
responses necessary to maintain a satisfactory 
quality of life’ (Barlow et al., 2002). 
They may include different elements, including 
psycho-education, relapse prevention, management 
of medication, symptoms management, setting 
individual recovery goals, and development of life 
skills (National Collaborating Centre for Mental 
Health, 2014).
Evidence on effectiveness
A literature review found 25 Randomised Controlled 
Trials suggesting that self-management for people 
with schizophrenia may reduce symptoms of 
psychosis and increase quality of life and functioning 
at the end of the intervention (NCCMH, 2014). 
Evidence on the impact on hospitalisation and service 
use was inconclusive. However, due to the low quality 
of the studies, caution is required.
E-mental health self-management interventions are 
developing rapidly (van der Krieke et al., 2014). The 
recent review of 28 studies suggested that self-
management interventions compared to standard 
care have a large effect on medication management, 
and a small effect on knowledge and satisfaction. 
However, the interpretation of the results needs to be 
cautious due to the diversity in interventions reviewed.
Evidence on cost-effectiveness
There is some evidence that self-management 
may help avoid some costs through a reduction in 
relapse and readmissions. A meta-analysis of self-
management interventions for schizophrenia found 
evidence of a significant reduction in relapse and 
readmissions, and an improvement in symptoms and 
adherence to medication (Zou et al., 2013). However, 
these results need cautious interpretation because 
only one study was from the United Kingdom – 
Glasgow (Atkinson et al., 1996). 
A pilot study comparing service costs before and 
after a peer support self-management intervention 
for people with severe mental illness in Wales found 
that mean total service costs increased over six 
months, but decreased over 12 months, although the 
differences were not statistically significant. Wellbeing 
and functional living skills improved at both six and 
12 months (Iemmi et al., 2014). However, the lack of a 
control group requires caution in interpretation.
Policy and practice implications
Overall, the evidence suggests that self-management is 
associated with better outcomes and potential savings 
in the short term. Better management of schizophrenia 
may have important long-term effects and budget 
implications not only on health and social care costs 
but also on employment and educational gain.
Conclusion
There is some limited evidence from outside the 
UK that self-management can reduce symptoms 
of psychosis and increase quality of life, as well 
as reduce the rate of relapse and readmission to 
inpatient care. More work is needed to evaluate cost 
effectiveness.
Further details: Valentina Iemmi (v.iemmi@lse.ac.uk)
3.12 Cognitive Behavioural Therapy 
Martin Knapp, Paul McCrone and  
David McDaid
Context
Many people can potentially benefit from 
psychological therapies. The Improving Access for 
Psychological Therapies (IAPT) programme has 
considerably widened access to psychological 
therapies for many people with mental health needs, 
but to date has primarily focused on people with 
common mental disorders such as depression and 
anxiety. The IAPT for Severe Mental Illness project 
(IAPT-SMI) is aiming to increase access to a range 
of NICE-recommended therapies, including CBT 
for people with psychosis, bipolar disorder and 
personality disorders.
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Intervention
Cognitive Behavioural Therapy (CBT) is a short-term 
talking therapy that focuses on thinking patterns  
and behaviour, often breaking down problems 
into small components so that straightforward 
interventions can be identified to address them. 
CBT tends to be more widely used than other 
psychological therapies. CBT has been shown to 
be beneficial in the treatment of depression, anxiety 
disorders and other conditions, but has been 
less widely offered or evaluated with people with 
schizophrenia and psychoses. 
Two national IAPT-SMI demonstration sites have 
been set up to deliver an IAPT service for psychosis 
– Lancashire and South London and Maudsley 
Foundation Trust (SLaM). The SLaM IAPT-SMI service 
comprises three clinical teams – early intervention, 
specialist recovery, and psychological therapy – 
providing specialist community mental health care 
for people with psychosis. The service offers NICE-
recommended, evidence-based interventions for 
people with psychosis. CBT involves weekly or 
fortnightly individual one-hour sessions over 6-9 
months (Johns, 2014).
Evidence on effectiveness
A review of evidence of CBT for people with 
schizophrenia concluded that the severity of 
psychiatric symptoms can be reduced, with 
an average effect size of 0.4 for patients taking 
antipsychotic medications (Wykes et al 2008). 
Morrison et al (2014) looked at cognitive therapy  
for people with schizophrenia spectrum disorders 
who were not taking their antipsychotic medications, 
and found a similar effect size, although there has 
been subsequent discussion of the robustness of  
the findings. 
The review undertaken for the recent NICE guidelines 
found consistent evidence from 19 controlled trials 
that CBT for people with schizophrenia was effective 
compared to care as usual in reducing hospitalisation 
rates for a period of up to 18 months. Time spent in 
hospital was also an average of eight days shorter.  
At 12 months people who had received CBT were 
more likely to have reduced depressive symptoms 
and improved social functioning. Individual-level  
CBT had more robust positive impacts than group-
based CBT.
Evidence on cost-effectiveness
Two economic evaluations were identified by NICE 
in their recent review and appraisal on the cost-
effectiveness of CBT for people with schizophrenia 
(Kuipers et al., 1998; Startup et al., 2005). Both 
studies were undertaken in the UK. The first focused 
on people with medication-resistant psychosis, with 
the economic analysis reporting better outcomes, 
and no significant difference in health and social 
care costs compared to standard care alone. The 
later study looked at CBT plus treatment as usual 
compared to treatment as usual alone in 90 people 
hospitalised for an acute psychotic episode in Wales. 
CBT had better clinical outcomes, with no statistical 
difference in health and social care costs. NICE also 
modelled the economic impacts of individualised 
CBT plus usual care compared to usual care alone. 
This model was found to be cost saving because 
of the reduction in the rates of future hospitalisation 
achieved. There was an overall net saving to the 
health and social care system of £989 per person 
with schizophrenia. 
Drawing on data collected in the SLaM IAPT-SMI 
service for people with psychosis (Johns 2014), we 
carried out new analyses of the impact of CBT on 
health-related quality of life. We compared these 
findings with the impact of ‘usual treatment’ for 
a similar group of people (Patel et al., 2013). The 
comparison allows us to offer a preliminary indication 
of the potential impact of the IAPT-SMI service.  
The estimated QALY accrual was 0.067 higher in the 
CBT group than for the comparison sample.  
The average number of CBT sessions was 13.7, for 
which the estimated cost was £134 per hour, giving  
a mean treatment cost of £1,834 per patient. This 
gives an approximate incremental cost per QALY of 
£27,373 for CBT compared to usual care, which is 
below the upper threshold used by NICE, and which 
therefore suggests that CBT may be considered  
cost-effective. 
A study of CBT for people with schizophrenia who 
were not taking prescribed antipsychotic medications 
found that the mean number of inpatient days during 
the treatment period was 1.3 for the CBT group and 
4.1 for the treatment as usual group (Morrison et al., 
2014). Applying the mean NHS Reference Cost for 
clusters relating to psychosis (£349 per bed-day) 
to these figures would bring the incremental cost-
effectiveness ratio down to £12,731. 
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Policy and practice implications
The IAPT programme is trialling CBT and other 
psychological therapies in two demonstration 
sites. Our preliminary analysis suggests that there 
may be an economic case for widening access 
to psychological therapies to include people with 
schizophrenia and psychosis. This is supported 
by the economic analyses carried out to support 
development of the recent NICE guidelines. Although 
the evidence is quite tentative at this stage, it 
provides economic encouragement for CBT as part of 
the treatment pathway for people with schizophrenia. 
Conclusion
Our preliminary analysis of data from the Improving 
Access for Psychological Therapies (IAPT) Severe 
Mental Illness project suggests an economic case for 
widening access to psychological therapies to include 
people with schizophrenia and psychosis. This is 
supported by the economic analyses carried out to 
support development of the recent NICE guidelines. 
Further details: Martin Knapp (m.knapp@lse.ac.uk)
3.13 Anti-stigma and discrimination 
campaigns
Valentina Iemmi and Martin Knapp
Context
The stigma experienced by many people with 
schizophrenia and psychosis can affect many 
aspects of their lives, limiting access to employment 
and housing, harming social relationships, reducing 
self-esteem and reducing the likelihood that they seek 
treatment. Social marketing campaigns have been 
suggested ‘as a way to reach the public, to modify 
health or pro-social behaviours and to promote 
specific health issues’ (Evans-Lacko et al 2013a).  
The Time to Change programme was launched 
in England in early 2009 in an attempt to change 
attitudes to mental health problems, and in particular 
to reduce discriminatory behaviour. 
Intervention
The Time to Change programme included an anti-
stigma social marketing campaign that made use 
of the mass media, including participation in mass 
social events. 
Evidence on effectiveness
The evaluation of the Time to Change social marketing 
campaign to reduce stigma and discrimination in 
relation to people with mental illness in England 2009-
2011 (Evans-Lacko et al., 2013b) compared knowledge, 
attitudes, and intended behaviours before and after 
each period of campaign activity. The analysis showed 
a modest but significant positive impact in the general 
adult population with an improvement in intended 
behaviours, but not consistent improvement in 
knowledge or attitudes after phase one of the Time 
to Change campaign. Awareness of the campaign 
was associated with better knowledge, attitudes 
and intended behaviour. However, the results should 
be treated cautiously because of the absence of a 
control group, the lack of measurement of actual 
behaviour, and the small sample size among some 
black and minority ethnic (BME) groups.
Evidence on cost-effectiveness 
This study includes an economic evaluation (Evan-
Lacko et al., 2013). Adapting the methodology used 
by McCrone et al. (2010), the economic analysis 
estimates the impact of reduced stigma and 
discrimination on service utilisation and employment 
for people suffering from depression under different 
scenarios (increased service use but unchanged 
employment rates, unchanged service use but 
increased employment rates, increased service use 
and employment rates). 
The campaign was found to be potentially cost-
effective and low cost, with economic benefits 
outweighing the financial costs. Under the 
conservative assumption that the campaign is 
responsible for 50% of the change, the cost per 
person with changed intended behaviour was at most 
£3.86, the cost per person with changed knowledge 
was at most £8.56, and the cost per person with 
changed attitudes was at most £10.94. 
Moreover, the cost of the entire Time to Change 
programme as a percentage of the total cost of 
mental health problems was low (0.04%) when 
compared with other public health programmes in the 
UK (e.g. 0.37% for obesity and 0.17% for stroke).
However, results may need to be interpreted with 
caution due to the focus on depression only, the lack 
of a control group, the lack of measurement of the 
actual behaviour, and the lack of long-term data.
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Policy and practice implications
The population-level improvements in attitudes and 
intended behaviour that flowed from the Time to 
Change programme should encourage both national 
and local efforts to address the persistence of 
negative attitudes to mental illness, particularly to 
serious mental illnesses such as schizophrenia and 
other psychoses. The evidence from the economic 
evaluation of Time to Change shows that an anti-
stigma social marketing campaign can also be 
potentially cost-effective. Similar results were found 
by McCrone et al (2010) in a less detailed evaluation 
of the Scottish See Me campaign.
Conclusion
Population-level improvements in attitudes and 
intended behaviour that flowed from the Time to 
Change programme should encourage national and 
local efforts to address the persistence of negative 
attitudes to mental illness, particularly to serious mental 
illnesses such as schizophrenia and other psychoses.
Further details:  
Sara Evans-Lacko (sara.evans-lacko@kcl.ac.uk)
3.14 Personal Budgets
Martin Knapp
Context
Personal Budgets (PBs) were central to the aims to 
‘modernise’ social care in England, and sat at the 
heart of the ‘personalisation’ agenda. In social care, 
the personal budget policy emphasis built on some 
years of experience with direct payments and on 
the more recent ‘In Control’ projects for people with 
learning disabilities. The aim was to give service 
users who were eligible for state support more direct 
control over the resources they have been assessed 
as needing. 
In recent years, we have also seen a pilot to examine 
how well Personal Health Budgets (PHBs) might 
perform, putting patients at the centre of decisions 
about their care. In both cases, it was expected that 
care and support systems would be more responsive 
to individual circumstances and preferences, and 
that empowering people who use services would 
contribute to their better health and wellbeing, whilst 
being cost-effective. 
Intervention
Two interventions can be considered here: PBs for 
social care, which can be taken in the form of a direct 
payment or a personal care account managed by the 
local authority; and PHBs. The focus is on people 
with mental health problems. 
Evidence on effectiveness and  
cost-effectiveness
Personal Budgets: The IBSEN study of what 
were at the time called individual budgets recruited 
almost 1000 users of adult social care services into 
a Randomised Controlled Trial (RCT) and studied 
process, effectiveness, cost-effectiveness, 
workforce, provider and broader implementation 
challenges (Glendinning et al., 2008), 4% of the 959 
people recruited into the trial sample were aged 
under 65 and using mental health services. This is 
therefore a relatively small sample from which to 
draw conclusions. 
For mental health service users, those in PB  
group reported significantly higher quality of life t
han the comparison group at six-month follow-up 
(Netten et al., 2012). Many of these people had not 
found the services available under conventional 
arrangements to their liking, and saw a PB as an 
opportunity for them to access more appropriate 
support. Although not significant statistically, the 
study data also suggested some tendency for 
psychological wellbeing to be better for those in the 
PB group. The assessment process for allocating 
PBs appeared to better at recognising individual 
needs than previous resource allocation mechanisms 
(Jones et al., 2012). The economic evaluation found 
that PBs were more cost-effective than standard 
arrangements, for people using mental health 
services. Overall the economic case was strong 
(Glendinning et al., 2008).
Personal Health Budgets: In this study of 2000 
people using a range of health services, people 
assigned to the PHB group were compared with 
people who received conventional service delivery, 
and followed up at 12 months (Forder et al., 2012). 
As with the evaluation of personal (social care) 
budgets, the people with mental health needs 
appeared to respond particularly well to the 
opportunity to take more responsibility for managing 
their care and support. 
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PHBs were cost-effective compared to the standard 
services received by the control group at the 90% 
confidence level. They were also cost-effective for the 
NHS continuing healthcare groups. One reason is that 
indirect costs were lower for PHB holders with mental 
health needs than they were for the comparison 
group (Forder et al., 2012). This led the research 
team to recommend that the offer of personal health 
budgets should initially be focussed on people with 
mental health needs or continuing healthcare needs 
as their primary condition.
 
Policy and practice implications
It is now a requirement that adults eligible for 
state-brokered social care should be offered the 
opportunity to hold a PB. On the NHS side, the policy 
position is that from April 2014 people with continuing 
health needs – which would presumably include 
many people with mental health needs – have a right 
to ask for a PHB, and from October 2014 they have 
the right to hold one.
There are implications for resource allocation 
principals and procedures, staff skills and therefore 
training, the availability of ongoing brokerage and 
related support, safeguarding against financial and 
other risks, the use of proportionate monitoring of 
expenditure, and local care service markets.
Conclusion
For people with mental health needs, PBs – whether 
social care or health – have been found to generate 
better outcomes than standard care arrangements. 
They are also more cost-effective for this group of 
service users. Individuals who wish to take more 
direct control over how their care or continuing health 
needs are to be met should receive appropriate 
encouragement and support. 
Further details: Martin Knapp (m.knapp@lse.ac.uk)
3.15 Welfare advice
Michael Parsonage and David McDaid
Context
Stressful life events are a common cause of relapse 
(Norman and Malla, 1993). These may take a variety 
of forms and include crises associated with welfare 
problems such as benefits, debt and housing. People 
with severe mental illness are at particularly high 
risk of experiencing such problems, often in multiple 
forms (Balmer et al., 2010). The combination of severe 
mental illness and persistent low income often results 
in extreme social isolation and many people in this 
situation lack the network of family and friends that 
would otherwise be a source of help when financial or 
other problems arise.
Severe mental illness may also compromise the 
capacity of individuals to deal with everyday 
problems. Relatively minor difficulties such as an 
unpaid debt can rapidly escalate, leading to highly 
stressful experiences, such as visits from bailiffs and 
threats of legal action or eviction, which may serve 
to trigger relapse. The scale of such problems is 
increasing as a result of insecurity and income losses 
that have been associated with current reforms of the 
benefit system.
Intervention
High Street advice services may lack knowledge of 
the particular difficulties faced by people with severe 
mental illness, including problems of communication 
and social interaction, while clinical staff lack 
expertise in complex welfare rights problems, 
particularly when these raise legal issues such as 
housing repossessions or evictions. 
These limitations suggest the need for a specialist 
advice service which combines expertise in welfare 
rights with understanding of severe mental illness. 
A small number of mental health trusts already use 
such a service and one example, the Sheffield Mental 
Health Citizens Advice Bureau, has been described 
in detail in a recent report (Parsonage, 2013). This 
is a dedicated service available to all mental health 
service users in Sheffield and supports around 
600 clients a year who are referred by clinical staff 
because of the complexity or severity of their welfare 
problems. The average cost of support is around 
£260 per client. 
Evidence on effectiveness
The general literature on welfare advice provides 
plenty of evidence that advice services can 
substantially increase the take-up of social security 
benefits and so deliver significant financial gains for 
clients (Adams et al., 2006). Low take-up of benefits 
has long been a problem for people with severe 
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mental illness, with one study finding that only a  
third of a sample of service users were getting 
their correct entitlement and all of the other two-
thirds were under-claiming (Frost-Gaskin et al., 
2003). Disruption, as well as low uptake of benefits, 
increased the risk of falling into debt.
In the case of debt, there is evidence that contact 
with face-to-face advice services is associated with 
a 56% likelihood of debt becoming manageable 
(Williams and Sansom, 2007), while telephone 
services achieve a success rate of 47% (Pleasence 
and Balmer, 2007). In comparison, only around a 
third of debt problems will be resolved without any 
intervention. There is also some evidence of good 
outcomes resulting from advice on housing problems 
for people with mental health problems (Balmer and 
Pleasence, 2012).
Such findings indicate that welfare advice can 
achieve a significant measure of success in helping 
clients resolve the immediate problems on which 
they are seeking help. As yet, however, there is little 
evidence that such success has a strongly beneficial 
impact on mental health, though in large measure 
this is because of shortcomings in the design of most 
research studies in this area. 
Evidence on cost-effectiveness
Existing economic modelling indicates that under 
nearly all scenarios a not-for-profit debt advice 
service that reaches people at risk of having mental 
health problems has better outcomes and lower 
costs to the health and legal systems over a two-year 
period than no action (Knapp et al., 2011). 
The report on the Sheffield advice service 
referenced above identified three main ways in  
which specialist advice for mental health service 
users can reduce the costs of health care: (i) 
reductions in inpatients’ lengths of inpatient stay 
(e.g. by resolving a complex benefits or housing 
problem and so enabling a service user to be 
discharged more quickly); (ii) prevention of 
homelessness (e.g. by directly negotiating with 
landlords in cases of rent arrears); and (iii) prevention 
of relapse (not only by directly acting on an immediate 
cause of acute stress which threatens to trigger 
relapse but also by reducing the vulnerability of 
clients to future problems through the development 
of improved coping mechanisms). 
Only a small number of successful interventions are 
needed for an advice service to generate sufficient 
savings to be good value for money. This is because 
the unit cost of advice is very low compared with 
the unit cost of crisis care. As seen, the cost of 
advice in the Sheffield service is £260 per client. In 
comparison, the cost of relapse is over £19,000 per 
episode, while the cost of homelessness to the public 
sector including the NHS is estimated at £24,000 to 
£30,000 a year per case (DCLG, 2012). 
Policy and practice implications
People with schizophrenia and psychosis are at high 
risk of experiencing a range of welfare problems such 
as unmanageable debt and homelessness, likely to 
have damaging and costly impact on their mental 
health. The current round of benefit reforms is adding 
a further layer of insecurity and stress. Specialist 
welfare advice is a low-cost intervention which offers 
some prospects of mitigating these adverse effects, 
though at present the evidence how best it can be 
delivered to reach as many people as possible as 
well as on its cost-effectiveness is best described as 
suggestive rather than conclusive. 
 
Conclusion
There is a case for investing in specialist welfare 
advice and debt management services. Research is 
needed on their effectiveness in reducing relapse, 
but only a small number of successful interventions 
would be needed to generate sufficient savings to be 
considered good value for money. 
Further details: Michael Parsonage 
(Michael.Parsonage@centreformentalhealth.org.uk)
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4. Addressing the evidence gaps
While	the	economic	case	for	investing	in	many	of	the	interventions	in	this	report	
is	strong,	some	of	the	interventions	that	we	have	analysed	need	further	careful	
evaluation	to	confirm	their	effectiveness	and	cost-effectiveness	for	local	clinical	
commissioning	groups.	This	is	particularly	the	case	for	interventions	where	the	
majority	of	the	evidence	on	effectiveness	is	drawn	from	work	outside	the	UK.		
In	addition,	there	are	other	areas	where	more	work	is	still	needed	to	understand	
what	works	in	order	to	help	inform	commissioning	decisions,	and	we	have	
already	discussed	the	limits	of	the	evidence	on	recovery	colleges.	
Another area where there are gaps in knowledge 
concerns support to remain in or return to education. 
Early adulthood, the late teens and early twenties are 
key years for obtaining education and training that 
increase earnings and wellbeing throughout life, but 
they are also the peak years for first experiencing 
psychosis. Evidence from other developed countries 
suggests that people with schizophrenia have, on 
average, far fewer educational qualifications and 
many report difficulties with basic skills such as 
reading and writing (Kessler et al., 2005; Waghorn et 
al., 2012). 
These adverse educational outcomes compound the 
impacts that symptoms of schizophrenia have on 
economic opportunities (Trajkovic, 2007). Both lower 
educational achievement and the poor labour market 
outcomes it contributes to also have a detrimental 
impact on clinical outcomes (Geddes et al., 1994; 
Kilian et al., 2012).
The importance of education for both employment 
and clinical outcomes for people with schizophrenia 
and psychosis should be the basis for examining the 
economic case for interventions and care pathways 
that put a serious value on improving educational 
attainment. However, much of the evidence on the 
effectiveness of supported education is dated, 
methodologically weak or limited in the outcomes 
considered (Rogers et al., 2010; Ellison et al., 2013). 
Indeed, one systematic review of the literature – by 
Rogers et al. (2010) – found only four studies, each of 
them well over a decade old. 
One small uncontrolled UK-based study looking at 
educational support services built into an Individual 
Placement and Support employment programme 
for individuals with first episode psychosis has 
positive results (Rinaldi et al 2010). It was successful 
at integrating individuals into open employment and 
mainstream education and training. 
Ellison and colleagues (2013) report some ongoing 
studies too. So, while empirical evidence on 
supported education is very limited due to a lack of 
experimental studies, small sample sizes and other 
methodological problems, there is a clear theoretical 
case for a focus on keeping young people with 
psychosis and schizophrenia in contact with the 
education system.
Attention has also begun to focus more on trying 
to prevent the onset of mental health problems; 
this report has already highlighted the benefits that 
can be realised if Early Detection services for first 
episode psychosis can reduce the risk of developing 
psychosis. Earlier in the report it has also been noted 
that there are cost-effective strategies to prevent 
the onset of physical health problems in people with 
schizophrenia. However, there are other preventive 
strategies that can also be explored. 
Stress and depression are significant risk factors 
for psychosis. More needs to be known about how 
investing in measures that successfully promote 
mental wellbeing, as well as preventing depression 
may also impact on new cases of schizophrenia. 
The report has already discussed the case for the 
use of CBT to help prevent psychosis; one recent 
review looked at drugs, behavioural therapies and 
nutritional supplement – Omega3 fatty acids – to 
prevent psychosis (Stafford et al 2013), but large 
well-conducted studies are required to build on this 
promising work.
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The economic case for investing in many mental 
health promotion interventions to reduce the risk of 
depressive disorders is compelling (Knapp, McDaid 
& Parsonage 2011), but it may be even more so if the 
benefits to the health sector of psychoses avoided 
are also factored in. It has also been argued that early 
identification and treatment of psychotic symptoms 
in people living with depression may be associated 
with reduced severity of psychosis, but again longer 
term follow up studies are needed to look at whether 
addressing psychotic symptoms in people living with 
other mental health problems does lead to better 
outcomes (van Os and Murray 2013).
Other areas where the evidence base was relatively 
limited and that would benefit from further 
investigation include the treatment of drug and 
alcohol problems, and psychological therapies 
other than CBT. Wykes et al. (2007) analysed the 
effectiveness of Cognitive Remediation Therapy 
(CRT) for cognitive difficulties experienced by people 
with schizophrenia, finding improvements in working 
memory as well as some improvement in cognitive 
flexibility. In an accompanying cost-effectiveness 
study, Patel et al. (2010) found no differences in health 
and social care costs or societal costs between the 
two groups over the follow-up period, but concluded 
that CRT would be seen as cost-effective compared 
to usual care given reasonable assumptions about 
decision-makers’ willingness to pay. Early evidence 
on adherence therapy suggested a possible cost-
effectiveness advantage (Healey et al. 1998), but 
a more recent European trial did not confirm this 
benefit (Gray et al., 2006; Patel et al., 2013).
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